Enabling openness of valuable information resources: Curbing data subtractability and exclusion

Digital entrepreneurship from cellular data: How omics afford the emergence of a new wave of digital ventures in health

Data has become an indispensable input, throughput, and output for the healthcare industry. In recent years, omics technologies such as genomics and proteomics have generated vast amounts of new data at the cellular level including molecular, structural, and functional levels. Cellular data holds the potential to innovate therapeutics, vaccines, diagnostics, consumer products, or even ancestry services. However, data at the cellular level is generated with rapidly evolving omics technologies. These technologies use scientific knowledge from resource-rich environments. This raises the question of how new ventures can use cellular-level data from omics technologies to create new products and scale their business. We report on a series of interviews and a focus group discussion with entrepreneurs, investors, and data providers. By conceptualizing omics technologies as external enablers, we show how characteristics of cellular-level data negatively affect the combination mechanisms that drive venture creation and growth. We illustrate how data characteristics set boundary conditions for innovation and entrepreneurship and highlight how ventures seek to mitigate their impact.

Supplementary Information

The online version contains supplementary material available at 10.1007/s12525-023-00669-w.

Perceived fairness of direct-to-consumer genetic testing business models

Although consumers and experts often express concerns regarding the questionable business practices of direct-to-consumer (DTC) genetic testing services (e.g., reselling of consumers' genetic data), the DTC genetic testing market keeps expanding rapidly. We employ retail fairness as our theoretical lens to address this seeming paradox and conduct a discrete choice experiment with 16 attributes to better understand consumers' fairness perceptions of DTC genetic testing business models. Our results suggest that, while consumers perceive privacy-preserving DTC genetic testing services fairer, price is the main driver for fairness perception. We contribute to research on consumer perceptions of DTC genetic testing by investigating consumer preferences of DTC genetic testing business models and respective attributes. Further, this research contributes to knowledge about disruptive business models in healthcare and retail fairness by contextualizing the concept of retail fairness in the DTC genetic testing market. We also demonstrate how to utilize discrete choice experiments to elicit perceived fairness.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12525-022-00571-x.

How are research data governed at Japanese repositories? A knowledge commons perspective

Purpose

The purpose of this paper is to survey how research data are governed at repositories in Japan by deductively establishing a governance typology based on the concept of openness in the context of knowledge commons and empirically assessing the conformity of repositories to each type.

Design/methodology/approach

The fuzzy-set ideal type analysis (FSITA) was adopted. For data collection, a manual assessment was conducted with all Japanese research data repositories registered on re3data.org.

Findings

The typology constructed in this paper consists of three dimensions: openness to resources (here equal to research data), openness to a community and openness to infrastructure provision. This paper found that there is no case where all dimensions are open, and there are several cases where the resources are closed despite research data repositories being positioned as a basis for open science in Japanese science and technology policy.

Originality/value

This is likely the first construction of the typology and application of FSITA to the study of research data governance based on knowledge commons. The findings of this paper provide practitioners insight into how to govern research data at repositories. The typology serves as a first step for future research on knowledge commons, for example, as a criterion of case selection in conducting in-depth case studies.

Communal data work: Data sharing and re-use in clinical genetics

In this article, we examine work with communal data in the context of clinical genetic testing. Drawing from prior research on digital research infrastructures and from the analysis of our empirical data on genetic testing, we describe how data generated in laboratories distributed all over the world are shared and re-used. Our research findings point to six different human-driven activities related to expanding, disambiguating, sanitizing and assessing the relevance, validity and combinability of data. We contribute to research within Health Informatics with a framework that foregrounds human-driven activities for data interoperability.